[
  {
    "ts": null,
    "headline": "3 Medical Stocks to Consider as Markets Take a Breather",
    "summary": "These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.",
    "url": "https://finnhub.io/api/news?id=4722e13b9af16368fbb2b6d6f08d8fef02ee9d500e0035cc3039d607b998879b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754081820,
      "headline": "3 Medical Stocks to Consider as Markets Take a Breather",
      "id": 136183198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.",
      "url": "https://finnhub.io/api/news?id=4722e13b9af16368fbb2b6d6f08d8fef02ee9d500e0035cc3039d607b998879b"
    }
  },
  {
    "ts": null,
    "headline": "Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.",
    "summary": "Graham owns an array of businesses including Kaplan test prep, and has family ties to Berkshire Hathaway. The stock looks cheap.",
    "url": "https://finnhub.io/api/news?id=cac9ad8b2700c1b11b1b53d36915c0f8be3ebf134417e8865130d70c0b404e51",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754081400,
      "headline": "Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.",
      "id": 136183199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Graham owns an array of businesses including Kaplan test prep, and has family ties to Berkshire Hathaway. The stock looks cheap.",
      "url": "https://finnhub.io/api/news?id=cac9ad8b2700c1b11b1b53d36915c0f8be3ebf134417e8865130d70c0b404e51"
    }
  },
  {
    "ts": null,
    "headline": "JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?",
    "summary": "JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.",
    "url": "https://finnhub.io/api/news?id=4529c86c12c6fc0607db89430bb89d47194c726af94acb465ee914ec4e4b468e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754059020,
      "headline": "JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?",
      "id": 136167113,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.",
      "url": "https://finnhub.io/api/news?id=4529c86c12c6fc0607db89430bb89d47194c726af94acb465ee914ec4e4b468e"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Value Portfolios Q2 2025 Commentary",
    "summary": "The Strategy outperformed its Russell 1000 Value benchmark during the second quarter.",
    "url": "https://finnhub.io/api/news?id=b49dd98a513195c6f714e1169b44a6dc409effe855e1c3253766b9917603c877",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754054820,
      "headline": "ClearBridge Value Portfolios Q2 2025 Commentary",
      "id": 136168212,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1452666698/image_1452666698.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The Strategy outperformed its Russell 1000 Value benchmark during the second quarter.",
      "url": "https://finnhub.io/api/news?id=b49dd98a513195c6f714e1169b44a6dc409effe855e1c3253766b9917603c877"
    }
  },
  {
    "ts": null,
    "headline": "Stryker lowers expected tariff impact to $175M",
    "summary": "The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing strength in procedure demand.",
    "url": "https://finnhub.io/api/news?id=c2962293fedcd36ea40418960e3173a15d5597679580dfa3a3bbc7e552c44e9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754053384,
      "headline": "Stryker lowers expected tariff impact to $175M",
      "id": 136183201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing strength in procedure demand.",
      "url": "https://finnhub.io/api/news?id=c2962293fedcd36ea40418960e3173a15d5597679580dfa3a3bbc7e552c44e9c"
    }
  },
  {
    "ts": null,
    "headline": "Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns",
    "summary": "Boost your portfolio with ADBE, DIS, INTU, ROL and JNJ as these five wide moat stocks poised for growth and strong returns.",
    "url": "https://finnhub.io/api/news?id=93ee456d0a05a5f6aae58115cb728d16e0ae544b251a911a2bcf0088046afc4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754046900,
      "headline": "Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns",
      "id": 136165257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Boost your portfolio with ADBE, DIS, INTU, ROL and JNJ as these five wide moat stocks poised for growth and strong returns.",
      "url": "https://finnhub.io/api/news?id=93ee456d0a05a5f6aae58115cb728d16e0ae544b251a911a2bcf0088046afc4a"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Stock: Analyst Estimates & Ratings",
    "summary": "Johnson & Johnson has outpaced the broader market and the healthcare sector in 2025, and analysts remain optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=f0d44b6088f604b30fcb81e3f1633c9124f128c48655d88bdda63c4ab00b77bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754034750,
      "headline": "Johnson & Johnson Stock: Analyst Estimates & Ratings",
      "id": 136165258,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson has outpaced the broader market and the healthcare sector in 2025, and analysts remain optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=f0d44b6088f604b30fcb81e3f1633c9124f128c48655d88bdda63c4ab00b77bb"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ) stands out as a financially strong company, being one of only two firms globally with a perfect AAA credit rating, higher than that of the US government. By the end of the second quarter, it […]",
    "url": "https://finnhub.io/api/news?id=c05ca4bcd99fb313e7124423859d694fa50e5252bf84e53ebada05c373d860d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754015356,
      "headline": "Johnson & Johnson’s (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock",
      "id": 136160909,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 10 Best Dividend Stocks to Buy for Retirement. Johnson & Johnson (NYSE:JNJ) stands out as a financially strong company, being one of only two firms globally with a perfect AAA credit rating, higher than that of the US government. By the end of the second quarter, it […]",
      "url": "https://finnhub.io/api/news?id=c05ca4bcd99fb313e7124423859d694fa50e5252bf84e53ebada05c373d860d6"
    }
  }
]